CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation

CryoLife, Inc. CRY today announced the expiration of the 20-day "go-shop" period that is part of its definitive agreement with Cardiogenesis Corporation, whereby CryoLife is conducting a cash tender offer for 49.9 percent of the outstanding shares of Cardiogenesis. During the "go-shop" period, Cardiogenesis was permitted, under the terms of the definitive agreement, to initiate, solicit and encourage proposals from, and engage in discussions with, third parties related to alternate acquisition proposals for a period of 20 days, which continued through April 17, 2011. Despite these solicitation efforts, Cardiogenesis did not receive any alternative acquisition proposals.